HDAC4 and epilepsy: As outlined in Section 6.3, genetic and epigenetic interventions—including HDAC4 silencing and microRNA-155 inhibition—modulate extrasynaptic receptor function, highlighting their therapeutic relevance in epilepsy, stroke, and neurodevelopmental disorders.